REPORT ID 5172

EMEA (Europe, Middle East and Africa) Personalized Medicine Market Report 2017

Publish Date
20-Dec-17
Pages
106
Format
Electronic (PDF)

In this report, the EMEA Personalized Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Personalized Medicine for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Personalized Medicine market competition by top manufacturers/players, with Personalized Medicine sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Laboratory Corporation of America
    Quest Diagnostics
    Abbott, Becton Dickinson & Co
    Siemens Healthcare Diagnostics Inc
    GE Healthcare
    Pfizer Inc
    Sanofi
    CardioDx
    Asuragen Inc
    Bristol-Myers Squibb

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Diagnostic
    Therapeutics
    Medical Care
    Nutrition
    Wellness

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Personalized Medicine for each application, including
    Hospitals
    Molecular Diagnostic Laboratories and Testing Centers
    Academic Institutes
    Bio and Health Informatics Companies
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Personalized Medicine Market Report 2017
1 Personalized Medicine Overview
    1.1 Product Overview and Scope of Personalized Medicine
    1.2 Classification of Personalized Medicine
        1.2.1 EMEA Personalized Medicine Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Personalized Medicine Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Diagnostic
        1.2.4 Therapeutics
        1.2.5 Medical Care
        1.2.6 Nutrition
        1.2.7 Wellness
    1.3 EMEA Personalized Medicine Market by Application/End Users
        1.3.1 EMEA Personalized Medicine Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospitals
        1.3.3 Molecular Diagnostic Laboratories and Testing Centers
        1.3.4 Academic Institutes
        1.3.5 Bio and Health Informatics Companies
        1.3.6 Others
    1.4 EMEA Personalized Medicine Market by Region
        1.4.1 EMEA Personalized Medicine Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Personalized Medicine (2012-2022)
        1.5.1 EMEA Personalized Medicine Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Personalized Medicine Revenue and Growth Rate (2012-2022)

2 EMEA Personalized Medicine Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Personalized Medicine Market Competition by Players/Manufacturers
        2.1.1 EMEA Personalized Medicine Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Personalized Medicine Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Personalized Medicine Sale Price by Players (2012-2017)
    2.2 EMEA Personalized Medicine (Volume and Value) by Type/Product Category
        2.2.1 EMEA Personalized Medicine Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Personalized Medicine Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Personalized Medicine Sale Price by Type (2012-2017)
    2.3 EMEA Personalized Medicine (Volume) by Application
    2.4 EMEA Personalized Medicine (Volume and Value) by Region
        2.4.1 EMEA Personalized Medicine Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Personalized Medicine Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Personalized Medicine Sales Price by Region (2012-2017)

3 Europe Personalized Medicine (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Personalized Medicine Sales and Value (2012-2017)
        3.1.1 Europe Personalized Medicine Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Personalized Medicine Revenue and Growth Rate (2012-2017)
    3.2 Europe Personalized Medicine Sales and Market Share by Type
    3.3 Europe Personalized Medicine Sales and Market Share by Application
    3.4 Europe Personalized Medicine Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Personalized Medicine Sales Volume by Countries (2012-2017)
        3.4.2 Europe Personalized Medicine Revenue by Countries (2012-2017)
        3.4.3 Germany Personalized Medicine Sales and Growth Rate (2012-2017)
        3.4.4 France Personalized Medicine Sales and Growth Rate (2012-2017)
        3.4.5 UK Personalized Medicine Sales and Growth Rate (2012-2017)
        3.4.6 Russia Personalized Medicine Sales and Growth Rate (2012-2017)
        3.4.7 Italy Personalized Medicine Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Personalized Medicine Sales and Growth Rate (2012-2017)

4 Middle East Personalized Medicine (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Personalized Medicine Sales and Value (2012-2017)
        4.1.1 Middle East Personalized Medicine Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Personalized Medicine Revenue and Growth Rate (2012-2017)
    4.2 Middle East Personalized Medicine Sales and Market Share by Type
    4.3 Middle East Personalized Medicine Sales and Market Share by Application
    4.4 Middle East Personalized Medicine Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Personalized Medicine Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Personalized Medicine Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Personalized Medicine Sales and Growth Rate (2012-2017)
        4.4.4 Israel Personalized Medicine Sales and Growth Rate (2012-2017)
        4.4.5 UAE Personalized Medicine Sales and Growth Rate (2012-2017)
        4.4.6 Iran Personalized Medicine Sales and Growth Rate (2012-2017)

5 Africa Personalized Medicine (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Personalized Medicine Sales and Value (2012-2017)
        5.1.1 Africa Personalized Medicine Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Personalized Medicine Revenue and Growth Rate (2012-2017)
    5.2 Africa Personalized Medicine Sales and Market Share by Type
    5.3 Africa Personalized Medicine Sales and Market Share by Application
    5.4 Africa Personalized Medicine Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Personalized Medicine Sales Volume by Countries (2012-2017)
        5.4.2 Africa Personalized Medicine Revenue by Countries (2012-2017)
        5.4.3 South Africa Personalized Medicine Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Personalized Medicine Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Personalized Medicine Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Personalized Medicine Sales and Growth Rate (2012-2017)

6 EMEA Personalized Medicine Manufacturers/Players Profiles and Sales Data
    6.1 Laboratory Corporation of America
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Personalized Medicine Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Laboratory Corporation of America Personalized Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Quest Diagnostics
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Personalized Medicine Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Quest Diagnostics Personalized Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Abbott, Becton Dickinson & Co
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Personalized Medicine Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Abbott, Becton Dickinson & Co Personalized Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Siemens Healthcare Diagnostics Inc
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Personalized Medicine Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Siemens Healthcare Diagnostics Inc Personalized Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 GE Healthcare
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Personalized Medicine Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 GE Healthcare Personalized Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Pfizer Inc
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Personalized Medicine Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Pfizer Inc Personalized Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Sanofi
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Personalized Medicine Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Sanofi Personalized Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 CardioDx
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Personalized Medicine Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 CardioDx Personalized Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Asuragen Inc
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Personalized Medicine Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Asuragen Inc Personalized Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Bristol-Myers Squibb
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Personalized Medicine Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Bristol-Myers Squibb Personalized Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Personalized Medicine Manufacturing Cost Analysis
    7.1 Personalized Medicine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Personalized Medicine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Personalized Medicine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Personalized Medicine Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Personalized Medicine Market Forecast (2017-2022)
    11.1 EMEA Personalized Medicine Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Personalized Medicine Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Personalized Medicine Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Personalized Medicine Price and Trend Forecast (2017-2022)
    11.2 EMEA Personalized Medicine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Personalized Medicine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Personalized Medicine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Personalized Medicine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Personalized Medicine Sales Forecast by Type (2017-2022)
    11.7 EMEA Personalized Medicine Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer